Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2000 Nov;76(901):734–735. doi: 10.1136/pmj.76.901.734

The real cost of aspirin

M Burgess 1, C Densem 1, N Brooks 1, R Levy 1, H Lee 1
PMCID: PMC1741813  PMID: 11060172

Abstract

Aspirin is a widely used drug and perceived by most physicians to be inexpensive. High rates of concurrent gastroprotective agents are reported from a study of cardiology outpatients. Aspirin takers are more likely to also be taking a proton pump inhibitor, H2 antagonist, or antacid than non-aspirin takers. They are more than 10 times as likely to be experiencing upper gastrointestinal symptoms. Although aspirin is inexpensive, it is emphasised that the overall cost implications for therapy can be significant and it is suggested that it may be more appropriate to consider the use of alternative antiplatelet agents in patients who tolerate aspirin poorly.


Keywords: aspirin; adverse effects; proton pump inhibitor

Full Text

The Full Text of this article is available as a PDF (72.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med. 1991 Oct 31;325(18):1261–1266. doi: 10.1056/NEJM199110313251801. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES